NOVO NORDISK A/S (NYSE: NVO) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by September 30, 2025
诺和诺德(US:NVO) Prnewswire·2025-09-17 12:12PHILADELPHIA , Sept. 17, 2025 /PRNewswire/ -- Berger Montague PC  is investigating claims under the federal securities laws against Novo Nordisk A/S (NYSE: NVO) ("Novo" or the "Company"), a global pharmaceutical company, headquartered in Denmark, after a class action lawsuit was filed against Novo. ...